Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants

by palligoelme@gmail.com | Oct 10, 2025 | Clinical Trials

​ Conditions: Healthy Volunteer Interventions: Drug: atirmociclib (PF-07220060) Sponsors: Pfizer Not yet recruiting Conditions: Healthy Volunteer Interventions: Drug: atirmociclib (PF-07220060) Sponsors: Pfizer Not yet...

Prescriptive Infusion Algorithm (PIA)

by palligoelme@gmail.com | Oct 10, 2025 | Clinical Trials

​ Conditions: PARKINSON DISEASE (Disorder) Interventions: Procedure: Prescriptive Infusion Algorithm; Drug: AB-1005 Sponsors: AskBio Inc; Bayer Not yet recruiting Conditions: PARKINSON DISEASE (Disorder) Interventions: Procedure: Prescriptive Infusion Algorithm; Drug:...

The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery

by palligoelme@gmail.com | Oct 9, 2025 | Clinical Trials

​ Conditions: Non-Diabetic Interventions: Drug: REMD-477 versus Placebo; Other: Exogenous glucagon versus saline infusion Sponsors: The University of Texas Health Science Center at San Antonio; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)...

Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder

by palligoelme@gmail.com | Oct 9, 2025 | Clinical Trials

​ Conditions: Bipolar Disorder (BD); Psychosis Interventions: Behavioral: Group-Based Psychoeducation; Behavioral: Peer Support; Behavioral: Personalized Support for Community Healthcare Provider Sponsors: McMaster University; St. Joseph’s Healthcare Hamilton...

Simvastatin Efficacy in ARID1A Mutated Advanced gastroESophageal Carcinoma Treated With Immunotherapy

by palligoelme@gmail.com | Oct 9, 2025 | Clinical Trials

​ Conditions: Advanced or Metastatic Gastrooesophageal Carcinoma Interventions: Drug: standard nivolumab and oxaliplatin- based chemotherapy; Drug: simvastatin in combination with standard nivolumab and oxaliplatin-based chemotherapy Sponsors: National Cancer...